Medical research

Drug cocktail reduces aging-associated disc degeneration

Chronic back pain affects upwards of 15 million adults in the US, racking up billions in healthcare costs and lost work days. Degeneration of the discs that cushion and support vertebrae, a common occurrence of aging, is ...

Medications

Antibody cocktail offers much-needed COVID-19 protection

In what could be very good news for the immunocompromised, an antibody cocktail tested at the University of Virginia School of Medicine appears to offer long-lasting protection from COVID-19.

Medications

Study identifies new potential treatments for COVID-19

A virtual screening of the DrugBank database has identified a variety of as yet unexplored ways to attack SARS-CoV-2, even as it mutates. The study identified drugs and possible cocktails that are shown to target vital proteins ...

Diseases, Conditions, Syndromes

Experimental drug may work against hepatitis C

(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.

page 1 from 3